A

Amar Remedies

AMAR

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Stock is trading at 0.06 times its book value
  • Company has delivered good profit growth of 23.6% CAGR over last 5 years

Growth Rate

Revenue Growth
17% lower than 3Y
Net Income Growth
29% higher than 3Y

Quarterly Results

Particulars Dec 2011Dec 2012Mar 2013Jun 2013
Sales
165
163
131
45
Expenses
140
145
122
53
Operating Profit
24
18
9
-8
OPM %
15%
11%
7%
-18%
Other Income
1
0
-7
-4
Interest
9
12
14
15
Depreciation
3
5
5
2
PBT
14
2
-16
-29
Tax %
12%
17%
0%
0%
Net Profit
12
1
-16
-29
EPS in Rs
4.69
0.51
-6.17
-11.03
Figures in ₹ Crores

Profit & Loss

Particulars Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Sales
167
202
298
369
472
578
674
Expenses
139
176
263
322
404
496
561
Operating Profit
28
26
35
48
68
82
113
OPM %
17%
13%
12%
13%
14%
14%
17%
Other Income
0
0
0
2
1
1
-3
Interest
3
4
8
12
21
27
40
Depreciation
1
2
2
7
10
11
13
PBT
24
21
26
30
38
45
57
Tax %
14%
17%
17%
11%
15%
15%
21%
Net Profit
21
17
22
27
32
38
45
EPS in Rs
8.01
6.51
8.32
10.2
12.33
14.54
17.29
Div. Payout %
0%
0%
0%
10%
8%
7%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Dec 2012
Equity Capital
26
26
26
26
26
26
26
26
Reserves
64
80
102
126
155
190
235
238
Borrowings
29
53
56
88
124
249
365
365
Other Liabilities
11
24
29
48
57
25
56
35
Total Liabilities
129
184
213
288
362
490
683
664
Fixed Assets
26
29
84
108
115
124
165
161
CWIP
16
52
0
0
0
11
0
0
Investments
0
0
0
0
1
1
1
1
Other Assets
87
102
129
180
246
354
518
502
Total Assets
129
184
213
288
362
490
683
664
Figures in ₹ Crores

Cash Flow

Particulars Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Operating
-9
15
2
3
-12
0
-21
Investing
-42
-40
-5
-31
-18
-49
-58
Financing
51
24
3
29
33
57
76
Net Cash Flow
0
0
0
1
3
8
-3
Free Cash Flow
-46
-26
-3
-28
-30
-31
-63
CFO/OP
-20
58
17
14
-18
8
-9
Figures in ₹ Crores

Ratios

Particulars Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Debtor Days
86
87
83
81
83
88
100
Inventory Days
100
95
103
138
111
122
167
Days Payable
6
11
7
14
9
10
11
Cash Conversion Cycle
180
171
179
205
186
199
255
Working Capital Days
157
134
119
127
141
185
230
ROCE %
18%
20%
20%
22%
19%
19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Amar Remedies insights

42 extracted metrics + investor summaries across FY11–FY12.

Log in — free

Documents

Frequently Asked Questions about Amar Remedies

What does Amar Remedies Ltd do?
Amar Remedies Limited, incorporated in India, listed on the Bombay Stock Exchange, and National Stock Exchange Limited, the company is engaged in Manufacuring and Trading of Ayurvedic Products and FMCG.
Which sector does Amar Remedies Ltd belong to?
Amar Remedies Ltd is classified under the Fast Moving Consumer Goods sector, in the Personal Products industry.

Company Information

Amar Remedies Limited, incorporated in India, listed on the Bombay Stock Exchange, and National Stock Exchange Limited, the company is engaged in Manufacuring and Trading of Ayurvedic Products and FMCG.

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AMAR.md for Amar Remedies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More